Stock chart
Ticker: FATE Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
Jan. 13, 2023 Jan. 13, 2023 B Purchase

MENDLEIN JOHN

Non-Executive Director
36,631 +14.9%
5.43
198,906 USD
36,631 +14.9% 5.43 198,906 USD
Jan. 13, 2023 Jan. 11, 2023 B Purchase

MENDLEIN JOHN

Non-Executive Director
88,048 +55.7%
5.67
499,232 USD
88,048 +55.7% 5.67 499,232 USD
July 25, 2022 July 22, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
620 -0.1%
33.28
20,634 USD
620 -0.1% 33.28 20,634 USD
July 25, 2022 July 22, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
2,703 -0.6%
32.61
88,145 USD
2,703 -0.6% 32.61 88,145 USD
July 25, 2022 July 22, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
2,923 -0.7%
31.33
91,578 USD
2,923 -0.7% 31.33 91,578 USD
July 25, 2022 July 21, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
19,171 -4.3%
33.07
633,985 USD
19,171 -4.3% 33.07 633,985 USD
July 25, 2022 July 21, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
10,829 -2.3%
32.54
352,376 USD
10,829 -2.3% 32.54 352,376 USD
July 8, 2022 July 7, 2022 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
17,158 -8.7%
30.23
518,686 USD
17,158 -8.7% 30.23 518,686 USD
July 7, 2022 July 6, 2022 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
7,842 -4.2%
30.07
235,809 USD
7,842 -4.2% 30.07 235,809 USD
June 2, 2022 June 1, 2022 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
25,000 -11.7%
22.96
574,000 USD
25,000 -11.7% 22.96 574,000 USD
April 25, 2022 April 22, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
838 -0.2%
35.15
29,456 USD
838 -0.2% 35.15 29,456 USD
April 25, 2022 April 22, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
9,162 -2.1%
34.54
316,455 USD
9,162 -2.1% 34.54 316,455 USD
April 25, 2022 April 21, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
1,003 -0.2%
37.90
38,014 USD
1,003 -0.2% 37.90 38,014 USD
April 25, 2022 April 21, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
2,220 -0.5%
36.70
81,474 USD
2,220 -0.5% 36.70 81,474 USD
April 25, 2022 April 21, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
4,062 -0.9%
35.73
145,135 USD
4,062 -0.9% 35.73 145,135 USD
April 25, 2022 April 21, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
22,715 -4.9%
34.57
785,258 USD
22,715 -4.9% 34.57 785,258 USD
April 4, 2022 April 1, 2022 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
25,000 -11.7%
38.85
971,250 USD
25,000 -11.7% 38.85 971,250 USD
March 15, 2022 March 14, 2022 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
100 -0.1%
34.04
3,404 USD
100 -0.1% 34.04 3,404 USD
March 15, 2022 March 14, 2022 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
2,960 -1.6%
33.30
98,568 USD
2,960 -1.6% 33.30 98,568 USD
March 15, 2022 March 14, 2022 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
2,195 -1.2%
32.49
71,316 USD
2,195 -1.2% 32.49 71,316 USD
March 15, 2022 March 14, 2022 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
3,067 -1.6%
31.66
97,101 USD
3,067 -1.6% 31.66 97,101 USD
March 15, 2022 March 14, 2022 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
16,678 -8.1%
30.36
506,344 USD
16,678 -8.1% 30.36 506,344 USD
March 11, 2022 March 10, 2022 PS Planned sale

MENDLEIN JOHN

Non-Executive Director
12,069 -7.0%
35.48
428,208 USD
12,069 -7.0% 35.48 428,208 USD
March 11, 2022 March 10, 2022 PS Planned sale

MENDLEIN JOHN

Non-Executive Director
19,493 -10.2%
34.73
676,992 USD
19,493 -10.2% 34.73 676,992 USD
Jan. 24, 2022 Jan. 21, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
10,000 -2.3%
38.02
380,200 USD
10,000 -2.3% 38.02 380,200 USD
Jan. 24, 2022 Jan. 20, 2022 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
30,000 -6.5%
40.21
1,206,300 USD
30,000 -6.5% 40.21 1,206,300 USD
Jan. 4, 2022 Jan. 3, 2022 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
861 -0.5%
60.31
51,927 USD
861 -0.5% 60.31 51,927 USD
Jan. 4, 2022 Jan. 3, 2022 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
27,812 -14.1%
59.86
1,664,826 USD
27,812 -14.1% 59.86 1,664,826 USD
Jan. 4, 2022 Jan. 3, 2022 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
16,900 -7.9%
58.84
994,396 USD
16,900 -7.9% 58.84 994,396 USD
Jan. 4, 2022 Jan. 3, 2022 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
4,427 -2.0%
57.76
255,704 USD
4,427 -2.0% 57.76 255,704 USD
Dec. 21, 2021 Dec. 20, 2021 PS Planned sale

Dulac Edward J III

Chief Financial Officer

Officer
15,977 -12.6%
60.00
958,620 USD
15,977 -12.6% 60.00 958,620 USD
Dec. 14, 2021 Dec. 13, 2021 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
1,600 -1.0%
49.27
78,832 USD
1,600 -1.0% 49.27 78,832 USD
Dec. 14, 2021 Dec. 13, 2021 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
7,718 -4.6%
48.75
376,253 USD
7,718 -4.6% 48.75 376,253 USD
Dec. 14, 2021 Dec. 13, 2021 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
6,564 -3.8%
47.61
312,512 USD
6,564 -3.8% 47.61 312,512 USD
Dec. 14, 2021 Dec. 13, 2021 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
7,018 -3.9%
46.72
327,881 USD
7,018 -3.9% 46.72 327,881 USD
Dec. 14, 2021 Dec. 13, 2021 PS Planned sale

Valamehr Bahram

Chief R&D Officer

Officer
2,100 -1.2%
45.68
95,928 USD
2,100 -1.2% 45.68 95,928 USD
Dec. 13, 2021 Dec. 10, 2021 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
5 -0.0%
55.54
278 USD
5 -0.0% 55.54 278 USD
Dec. 13, 2021 Dec. 10, 2021 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
600 -0.5%
54.58
32,748 USD
600 -0.5% 54.58 32,748 USD
Dec. 13, 2021 Dec. 10, 2021 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
1,031 -0.8%
53.66
55,323 USD
1,031 -0.8% 53.66 55,323 USD
Dec. 13, 2021 Dec. 10, 2021 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
1,822 -1.4%
52.37
95,418 USD
1,822 -1.4% 52.37 95,418 USD
Dec. 13, 2021 Dec. 10, 2021 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
1,045 -0.8%
51.08
53,379 USD
1,045 -0.8% 51.08 53,379 USD
Dec. 13, 2021 Dec. 10, 2021 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
900 -0.7%
50.42
45,378 USD
900 -0.7% 50.42 45,378 USD
Dec. 13, 2021 Dec. 10, 2021 PS Planned sale

Chu Yu-Waye

Senior VP Clinical Development

Officer
2,097 -1.6%
49.32
103,424 USD
2,097 -1.6% 49.32 103,424 USD
Nov. 22, 2021 Nov. 18, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
20,000 -4.8%
54.27
1,085,400 USD
20,000 -4.8% 54.27 1,085,400 USD
Oct. 25, 2021 Oct. 22, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
30,000 -7.1%
58.88
1,766,400 USD
30,000 -7.1% 58.88 1,766,400 USD
Oct. 25, 2021 Oct. 21, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
14,765 -3.6%
60.63
895,202 USD
14,765 -3.6% 60.63 895,202 USD
Oct. 25, 2021 Oct. 21, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
15,235 -3.6%
59.82
911,358 USD
15,235 -3.6% 59.82 911,358 USD
Oct. 4, 2021 Oct. 1, 2021 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
11,844 -9.9%
59.68
706,862 USD
11,844 -9.9% 59.68 706,862 USD
Oct. 4, 2021 Oct. 1, 2021 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
21,844 -15.4%
58.96
1,287,966 USD
21,844 -15.4% 58.96 1,287,966 USD
Oct. 4, 2021 Oct. 1, 2021 PS Planned sale

TAHL CINDY

General Counsel and Secretary

Officer
16,312 -10.3%
58.03
946,634 USD
16,312 -10.3% 58.03 946,634 USD
Sept. 14, 2021 Sept. 13, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
800 -0.8%
67.46
53,965 USD
800 -0.8% 67.46 53,965 USD
Sept. 14, 2021 Sept. 13, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,391 -8.0%
66.84
560,879 USD
8,391 -8.0% 66.84 560,879 USD
Sept. 14, 2021 Sept. 13, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
15,809 -13.1%
65.94
1,042,414 USD
15,809 -13.1% 65.94 1,042,414 USD
June 16, 2021 June 14, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
400 -0.4%
90.76
36,303 USD
400 -0.4% 90.76 36,303 USD
June 16, 2021 June 14, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,220 -7.9%
89.68
737,155 USD
8,220 -7.9% 89.68 737,155 USD
June 16, 2021 June 14, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
16,380 -13.6%
89.11
1,459,587 USD
16,380 -13.6% 89.11 1,459,587 USD
April 26, 2021 April 23, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
30,000 -7.1%
85.24
2,557,284 USD
30,000 -7.1% 85.24 2,557,284 USD
April 26, 2021 April 22, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
30,000 -7.1%
85.54
2,566,212 USD
30,000 -7.1% 85.54 2,566,212 USD
March 16, 2021 March 15, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
1,018 -1.1%
94.59
96,297 USD
1,018 -1.1% 94.59 96,297 USD
March 16, 2021 March 15, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
3,205 -3.2%
93.75
300,461 USD
3,205 -3.2% 93.75 300,461 USD
March 16, 2021 March 15, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,404 -7.8%
92.64
778,578 USD
8,404 -7.8% 92.64 778,578 USD
March 16, 2021 March 15, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
8,416 -7.2%
91.94
773,782 USD
8,416 -7.2% 91.94 773,782 USD
March 16, 2021 March 15, 2021 PS Planned sale

Valamehr Bahram

Chief Development Officer

Officer
3,957 -3.3%
90.89
359,654 USD
3,957 -3.3% 90.89 359,654 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
800 -1.1%
86.70
69,360 USD
800 -1.1% 86.70 69,360 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,900 -3.8%
85.50
247,956 USD
2,900 -3.8% 85.50 247,956 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,728 -3.4%
84.20
229,705 USD
2,728 -3.4% 84.20 229,705 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,480 -3.0%
83.46
206,989 USD
2,480 -3.0% 83.46 206,989 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
2,993 -3.5%
81.60
244,224 USD
2,993 -3.5% 81.60 244,224 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
5,174 -5.7%
80.73
417,722 USD
5,174 -5.7% 80.73 417,722 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
4,627 -4.9%
79.58
368,236 USD
4,627 -4.9% 79.58 368,236 USD
March 9, 2021 March 8, 2021 PS Planned sale

Shoemaker Daniel D

Chief Scientific Officer

Officer
3,298 -3.4%
78.60
259,236 USD
3,298 -3.4% 78.60 259,236 USD
Feb. 19, 2021 Feb. 18, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
5,547 -1.4%
103.16
572,206 USD
5,547 -1.4% 103.16 572,206 USD
Feb. 19, 2021 Feb. 18, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
8,602 -2.1%
102.26
879,661 USD
8,602 -2.1% 102.26 879,661 USD
Feb. 19, 2021 Feb. 18, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
2,602 -0.6%
101.42
263,883 USD
2,602 -0.6% 101.42 263,883 USD
Feb. 19, 2021 Feb. 18, 2021 PS Planned sale

Wolchko J Scott

President and CEO

Executive Director
1,848 -0.4%
100.48
185,691 USD
1,848 -0.4% 100.48 185,691 USD